X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12264) 12264
Magazine Article (32) 32
Book / eBook (22) 22
Newsletter (17) 17
Book Chapter (15) 15
Conference Proceeding (6) 6
Book Review (3) 3
Dissertation (2) 2
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6450) 6450
pharmacology & pharmacy (5113) 5113
quinolones - pharmacology (4932) 4932
animals (3853) 3853
microbiology (3342) 3342
quinolones (3046) 3046
microbial sensitivity tests (2952) 2952
male (2865) 2865
anti-bacterial agents - pharmacology (2713) 2713
fluoroquinolones (2707) 2707
female (2155) 2155
infectious diseases (1948) 1948
anti-infective agents - pharmacology (1820) 1820
ciprofloxacin (1611) 1611
quinolones - therapeutic use (1545) 1545
adult (1371) 1371
rats (1106) 1106
chemistry, medicinal (1101) 1101
ciprofloxacin - pharmacology (1078) 1078
escherichia-coli (1078) 1078
middle aged (1025) 1025
drug resistance, bacterial (1022) 1022
mice (1009) 1009
antibiotics (1007) 1007
quinolones - chemistry (983) 983
quinolone resistance (975) 975
aripiprazole (968) 968
mutation (950) 950
quinolone (932) 932
dose-response relationship, drug (909) 909
fluoroquinolones - pharmacology (906) 906
structure-activity relationship (850) 850
escherichia coli - drug effects (841) 841
quinolones - administration & dosage (836) 836
bacteria (762) 762
resistance (737) 737
drug resistance (720) 720
quinolones - adverse effects (716) 716
quinolones - pharmacokinetics (714) 714
analysis (683) 683
biochemistry & molecular biology (681) 681
research article (660) 660
aged (656) 656
dna gyrase (653) 653
pharmacokinetics (647) 647
prevalence (621) 621
drug resistance, bacterial - genetics (617) 617
piperazines - therapeutic use (608) 608
quinolones - chemical synthesis (605) 605
levofloxacin (594) 594
research (593) 593
psychiatry (591) 591
in-vitro (582) 582
susceptibility (575) 575
drug resistance, microbial (574) 574
dna gyrase - genetics (567) 567
drug resistance in microorganisms (559) 559
antimicrobial resistance (548) 548
escherichia coli - genetics (535) 535
antipsychotic agents - therapeutic use (533) 533
infections (533) 533
adolescent (525) 525
anti-infective agents - pharmacokinetics (518) 518
biochemical phenomena, metabolism, and nutrition (515) 515
quinolone antibacterial agents (514) 514
bacterial proteins - genetics (512) 512
treatment outcome (509) 509
molecular structure (506) 506
piperazines - pharmacology (504) 504
genes (494) 494
mechanisms (490) 490
mutations (488) 488
oncology (479) 479
anti-infective agents - therapeutic use (464) 464
bacteria - drug effects (460) 460
anti-bacterial agents - therapeutic use (453) 453
drug therapy (452) 452
strains (452) 452
administration, oral (443) 443
antibiotic-resistance (442) 442
ofloxacin - pharmacology (440) 440
fluoroquinolone (431) 431
time factors (431) 431
bacterial infections and mycoses (429) 429
in vitro techniques (426) 426
internal medicine (422) 422
ofloxacin (422) 422
immunology (421) 421
polymerase chain reaction (418) 418
fluoroquinolone resistance (416) 416
antimicrobial agents (412) 412
schizophrenia (412) 412
pharmacology/toxicology (410) 410
health aspects (407) 407
pharmacology (406) 406
medicine & public health (403) 403
plasmids (399) 399
piperazines - adverse effects (396) 396
neurosciences (395) 395
staphylococcus aureus - drug effects (395) 395
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Online Resources - Online (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12068) 12068
Japanese (303) 303
Spanish (85) 85
French (77) 77
Chinese (59) 59
German (59) 59
Russian (27) 27
Portuguese (26) 26
Turkish (9) 9
Hungarian (6) 6
Polish (6) 6
Italian (5) 5
Slovak (4) 4
Korean (3) 3
Czech (2) 2
Romanian (2) 2
Bulgarian (1) 1
Dutch (1) 1
Finnish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Neuropsychopharmacology, ISSN 0924-977X, 2015, Volume 25, Issue 4, pp. 505 - 511
Journal Article
1983, The Society for Applied Bacteriology / technical series, ISBN 0126044805, Volume no. 18, xvi, 384
Book
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 04/2008, Volume 117, Issue 4, pp. 253 - 259
Shelton RC, Papakostas GI. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Objective:  Atypical... 
antidepressants | major depressive disorder | treatment resistant | augmentation | atypical antipsychotics | Augmentation | Treatment resistant | Atypical antipsychotics | Antidepressants | Major depressive disorder | STAR-ASTERISK-D | OLANZAPINE/FLUOXETINE COMBINATION | PSYCHIATRY | ARIPIPRAZOLE AUGMENTATION | OPEN-LABEL | DOPAMINERGIC-NEURONS | SEROTONIN REUPTAKE INHIBITORS | DOUBLE-BLIND | OLANZAPINE | RISPERIDONE AUGMENTATION | ZIPRASIDONE | Trazodone - therapeutic use | Humans | Quinolones - pharmacology | Thiazoles - therapeutic use | Aripiprazole | Serotonin 5-HT2 Receptor Antagonists | Dibenzothiazepines - therapeutic use | Trazodone - pharmacology | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Antidepressive Agents - pharmacology | Fluoxetine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Depressive Disorder, Major - drug therapy | Triazoles - therapeutic use | Fluoxetine - pharmacology | Benzodiazepines - pharmacology | Dibenzothiazepines - pharmacology | Quetiapine Fumarate | Piperazines - therapeutic use | Piperazines - pharmacology | Antidepressive Agents - therapeutic use | Triazoles - pharmacology | Thiazoles - pharmacology | Antipsychotic Agents - pharmacology | Benzodiazepines - therapeutic use | Dopamine D2 Receptor Antagonists | Serotonin uptake inhibitors | Antipsychotic drugs | Antidepressants, Tricyclic | Clinical trials | Pharmacology | Biochemistry | Mental depression | Psychiatry | Suicides & suicide attempts
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 2008, Volume 47, Issue 10, pp. 635 - 654
Journal Article
Psychopharmacology (Berlin, Germany), ISSN 1432-2072, 2016, Volume 234, Issue 4, pp. 525 - 533
Addition of low doses of atypical antipsychotic drugs with selective serotonin reuptake inhibitors (SSRIs) could promote a rapid antidepressant effect in... 
SSRI | Neurosciences | Biomedicine | Fluoxetine | Spine | Brexpiprazole | Inflammation | Pharmacology/Toxicology | Psychiatry | PSYCHIATRY | ADJUNCTIVE BREXPIPRAZOLE | INADEQUATE RESPONSE | ARIPIPRAZOLE AUGMENTATION | NEUROTROPHIC FACTOR BDNF | NECROSIS-FACTOR-ALPHA | DOPAMINE ACTIVITY MODULATOR | NEUROSCIENCES | SEROTONIN 5-HT1A | SERUM-LEVELS | DOUBLE-BLIND | DISORDER | PHARMACOLOGY & PHARMACY | Thiophenes - therapeutic use | Male | Dendritic Spines - metabolism | Quinolones - pharmacology | Depression - drug therapy | Depression - metabolism | Inflammation - metabolism | Prefrontal Cortex - drug effects | Antipsychotic Agents - therapeutic use | Dendritic Spines - drug effects | Inflammation - drug therapy | Quinolones - therapeutic use | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Neurons - metabolism | Fluoxetine - therapeutic use | Neurons - drug effects | Fluoxetine - pharmacology | Thiophenes - pharmacology | Antidepressive Agents - therapeutic use | Animals | Signal Transduction - drug effects | Prefrontal Cortex - metabolism | Mice | Antipsychotic Agents - pharmacology | Antidepressants | Dosage and administration | Drug therapy, Combination | Drug therapy | Methods | Major depressive disorder | Studies | Psychopharmacology | Analysis | Original Investigation
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 21, pp. 2013 - 2023
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2011, Volume 213, Issue 1, pp. 131 - 141
Research using a drug discriminated goal-tracking (DGT) task showed that the N-methyl-d-aspartate (NMDA) channel blocker MK-801 (dizocilpine) reduced the... 
Drug discrimination | Neurosciences | Tobacco addiction | Mecamylamine | NR2B | Biomedicine | Discriminated goal-tracking | NMDA | Appetitive Pavlovian conditioning | Pharmacology/Toxicology | Psychiatry | State-dependent learning | Smoking | 1-AMINOCYCLOPROPANECARBOXYLIC ACID | PREPULSE INHIBITION | PSYCHIATRY | PUTATIVE PARTIAL AGONIST | D-ASPARTATE RECEPTOR | NEUROSCIENCES | GLUTAMATE-RECEPTOR | PHARMACOLOGICAL SPECIFICITY | CORTICAL-NEURONS | GLYCINE-SITE | PHARMACOLOGY & PHARMACY | NR2B SUBUNITS | DRUG-DISCRIMINATION | Phencyclidine - pharmacology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | 2-Amino-5-phosphonovalerate - pharmacology | Male | Quinolones - pharmacology | Brain - physiology | N-Methylaspartate - pharmacology | Nicotine - pharmacology | Dose-Response Relationship, Drug | Drug Interactions | Piperidines - pharmacology | Mecamylamine - pharmacology | Discrimination (Psychology) - drug effects | Phenols - pharmacology | Conditioning, Classical - drug effects | Rats | Excitatory Amino Acid Antagonists - pharmacology | Cyclopentanes - pharmacology | Conditioning, Classical - physiology | Nicotine - antagonists & inhibitors | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptors, N-Methyl-D-Aspartate - physiology | Brain - drug effects | Animals | 2-Amino-5-phosphonovalerate - analogs & derivatives | Discrimination (Psychology) - physiology | Dizocilpine Maleate - pharmacology | Neurotransmitters | Pharmacology | Antagonist drugs | Rodents | Nicotine
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 10/2006, Volume 13, Issue 23, pp. 2795 - 2818
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2014, Volume 74, Issue 1, pp. 75 - 97
A new single-tablet, fixed-dose formulation consisting of elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI); cobicistat, a pharmacokinetic... 
PROTEASE INHIBITOR | TWICE-DAILY RALTEGRAVIR | ONCE-DAILY ELVITEGRAVIR | CO-FORMULATED ELVITEGRAVIR | DOUBLE-BLIND | INITIAL TREATMENT | PHARMACOLOGY & PHARMACY | TOXICOLOGY | DRUG-RESISTANCE | ANTIRETROVIRAL TREATMENT | MOLECULAR-BASIS | INTEGRASE INHIBITORS | Anti-HIV Agents - pharmacology | Tablets | Humans | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Deoxycytidine - pharmacology | Quinolones - pharmacology | Thiazoles - therapeutic use | Carbamates - pharmacokinetics | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Deoxycytidine - pharmacokinetics | Deoxycytidine - therapeutic use | Adenine - adverse effects | Quinolones - adverse effects | Adenine - therapeutic use | Quinolones - pharmacokinetics | Quinolones - therapeutic use | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Carbamates - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Organophosphonates - adverse effects | Adenine - pharmacology | Adenine - pharmacokinetics | Organophosphonates - pharmacokinetics | Organophosphonates - pharmacology | Anti-HIV Agents - pharmacokinetics | Carbamates - adverse effects | HIV Infections - drug therapy | Thiazoles - pharmacology | Carbamates - therapeutic use | Drug Combinations
Journal Article